Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

Efavirenz (also known as DMP 266 or SUSTIVA) is a potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity and of HIV-1 replication in vitro and in vivo. Most patients on efavirenz-containing regimens have sustained antiviral responses; howeve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bacheler, Lee, Jeffrey, Susan, Hanna, George, D'Aquila, Richard, Wallace, Lany, Logue, Kelly, Cordova, Beverly, Hertogs, Kurt, Larder, Brendan, Buckery, Renay, Baker, David, Gallagher, Karen, Scarnati, Helen, Tritch, Radonna, Rizzo, Chris
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2001
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC114903/
https://ncbi.nlm.nih.gov/pubmed/11333879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.11.4999-5008.2001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars